|Bid||238.50 x 900|
|Ask||240.50 x 1200|
|Day's Range||238.37 - 242.48|
|52 Week Range||210.28 - 276.69|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||19.86|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||7.04 (2.95%)|
|Ex-Dividend Date||May 14, 2021|
|1y Target Est||254.96|
Trading volumes indicate that traders have been selling calls and buying puts in anticipation of an unfavorable earnings report.
Let us take a look at four drug/biotech companies, LLY, AMGN, INCY and ALNY, which are gearing up for their earnings release.
Carter Worth and Mike Khouw teamed up on CNBC's "Options Action" to give the viewers a bearish trade in Amgen, Inc. (NASDAQ: AMGN) ahead of earnings. Worth analyzed the stock from a technical standpoint and he concluded the stock doesn't act well. In the last week, Health Care Select Sector SPDR Fund (NYSE: XLV) gained 0.7%, which was enough to beat the market. Amgen, on the other hand, dropped 2.2% and underperformed both the sector and the market. Its monthly performance was not good either. I